Exact Mass: 720.3615

Ritonavir

C37H48N6O5S2 (720.3127)

Ritonavir is only found in individuals that have used or taken this drug. It is an HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. [PubChem]Ritonavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Voacorine

C43H52N4O6 (720.3887)

PC(2:0/LTE4)

C33H57N2O11PS (720.3421)

PC(2:0/LTE4) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/LTE4), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Leukotriene E4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

PC(LTE4/2:0)

C33H57N2O11PS (720.3421)

PC(LTE4/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(LTE4/2:0), in particular, consists of one chain of one Leukotriene E4 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).

Cucurbitacin B 2-O-beta-D-glucoside

C38H56O13 (720.3721)

25-O-Acetylbryoamaride

C38H56O13 (720.3721)

19-20-Epoxyconoduramine

C43H52N4O6 (720.3887)

Beesioside I

C39H60O12 (720.4085)

Cononitarine B

C43H52N4O6 (720.3887)

Candicanoside A

C39H60O12 (720.4085)

Bafilomycin C1

C39H60O12 (720.4085)

Larixsin

C40H48O12 (720.3146)

Opercurin B

C38H56O13 (720.3721)

Hebelomic acid B

C39H60O12 (720.4085)

MCULE-1828850748

C35H60O15 (720.3932)

19(S)-hydroxyconoduramine

C43H52N4O6 (720.3887)

rausutrine

C42H48N4O7 (720.3523)

16alpha-[(6-O-sulfo-beta-D-glucopyranosyl)oxy]pregn-5-en-20-ol-3beta-yl O-beta-D-oleandropyranoside

C34H56O14S (720.3391)

briaexcavatolide R

C38H56O13 (720.3721)

3-O-(2-O-Methyl-beta-D-xylopyranoside),15-sulfate-(3beta,6beta,8beta,15alpha,16beta,24R)-Stigmast-4-ene-3,6,8,15,16,29-hexol

C35H60O13S (720.3754)

C40H48O12

C40H48O12 (720.3146)

gukulenin B

C42H56O10 (720.3873)

(2beta,3beta,4alpha,16beta)-3-[(4-O-acetyl-6-O-methyl-beta-D-glucopyranuronosyl)oxy]-2,16-dihydroxy-15-oxo-28-norolean-12-en-23-oic acid

C38H56O13 (720.3721)

12beta,25-O-diacetylcimigenol-3-O-beta-D-xylopyranoside|25-O-acetyl-12beta-acetoxycimigenol-3-O-beta-D-xylopyranoside

C39H60O12 (720.4085)

datiscoside G

C38H56O13 (720.3721)

19(R)-hydroxyconodurine

C43H52N4O6 (720.3887)

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-alpha-rhamnopyranoside tetraacetate

C39H60O12 (720.4085)

sucrose ester MW 720

C35H60O15 (720.3932)

javanicinoside E

C37H52O14 (720.3357)

deformylcoryzeylamine

C43H52N4O6 (720.3887)

salarin B

C36H52N2O13 (720.3469)

Antibiotic A 54556E

C38H52N6O8 (720.3846)

C39H60O12

C39H60O12 (720.4085)

acutilobin D

C40H48O12 (720.3146)

(3R)-hydroxyconodurine

C43H52N4O6 (720.3887)

3-hydroxyvoacamine

C43H52N4O6 (720.3887)

fruticoside H|spirosta-5,25(27)-diene-1beta,3beta-diol-1-O-alpha-L-rhamnopyranosyl-(1?2)-beta-D-fucopyranoside

C39H60O12 (720.4085)

cayaponoside A3

C39H60O12 (720.4085)

2,3,4-tri-O-(5-methylhexanoyl)-alpha-D-glucopyranosyl 6-O-acetyl-beta-D-fructofuranoside

C35H60O15 (720.3932)

beta-D-glucopyranosyl (3beta)-29-acetoxy-3-hydroxy-23-methoxy-23-oxoolean-12-en-28-oate|kalidiumoside B

C39H60O12 (720.4085)

C35H60O15

C35H60O15 (720.3932)

Euphohelin C

C40H48O12 (720.3146)

sculoponin D

C40H48O12 (720.3146)

3R/S-hydroxyvoacamine

C43H52N4O6 (720.3887)

His Trp Asp His Leu

C34H44N10O8 (720.3343)

Arvenin I

C38H56O13 (720.3721)

Arvenin I is a natural product found in Streptomyces, Helicteres angustifolia, and other organisms with data available.

Ritonavir

C37H48N6O5S2 (720.3127)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2192 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2580 EAWAG_UCHEM_ID 2580; CONFIDENCE standard compound

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate

C35H60O15 (720.3932)

C38H56O13_(2S,4R,9beta,16alpha,17xi,23E)-2-(beta-D-Glucopyranosyloxy)-16,20-dihydroxy-9,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate

C38H56O13 (720.3721)

[(E,6R)-6-hydroxy-6-[(2S,8S,9R,10R,13R,14S,16R)-16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate

C38H56O13 (720.3721)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate

C35H60O15 (720.3932)

3-oxotabernaelegantine B

C43H52N4O6 (720.3887)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate_major

C35H60O15 (720.3932)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate_22.6\\%

C35H60O15 (720.3932)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate_66.1\\%

C35H60O15 (720.3932)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate_35.8\\%

C35H60O15 (720.3932)

[2-[4-hydroxy-2,5-bis(hydroxymethyl)-3-(3-methylbutanoyloxy)oxolan-2-yl]oxy-6-(hydroxymethyl)-4,5-bis(2-methylpropanoyloxy)oxan-3-yl] decanoate_65.2\\%

C35H60O15 (720.3932)

[(E,6R)-6-hydroxy-6-[(2S,8S,9R,10R,13R,14S,16R)-16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate_major

C38H56O13 (720.3721)

[(E,6R)-6-hydroxy-6-[(2S,8S,9R,10R,13R,14S,16R)-16-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate_minor

C38H56O13 (720.3721)

23R,24S-diacetoxy-3beta,15alpha,25-trihydroxy-cycloart-7-en-16-one-3-O-beta-D-xylopyranoside

C39H60O12 (720.4085)

Alstoyunine E

C42H40N8O4 (720.3172)

(S)-Fmoc-2-amino-5-[(N-Pbf-N-tert-butoxy)-guanidino]-pentanoic acid

C38H48N4O8S (720.3193)

Boc-Glu-Lys-Lys-AMC acetate salt

C34H52N6O11 (720.3694)

bis[(benzo-15-crown-5)-15-ylmethyl] pimelate

C37H52O14 (720.3357)

N,N-diphenyl-N,N-bis(9,9-dimethylfluoren-2-yl)benzidine

C54H44N2 (720.3504)

Tirilazad mesylate

C39H56N6O5S (720.4033)

D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents > D000975 - Antioxidants

N-[3-hydroxy-5-[[3-methyl-2-[[[methyl-[(2-propan-2-yl-4-thiazolyl)methyl]amino]-oxomethyl]amino]-1-oxobutyl]amino]-1,6-diphenylhexan-2-yl]carbamic acid 5-thiazolylmethyl ester

C37H48N6O5S2 (720.3127)

1,3-thiazol-5-ylmethyl N-[(2S,5S)-3-hydroxy-5-[[3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate

C37H48N6O5S2 (720.3127)

Acylsucrose S4:23[1]*

C35H60O15 (720.3932)

PC(2:0/LTE4)

C33H57N2O11PS (720.3421)

PC(LTE4/2:0)

C33H57N2O11PS (720.3421)

3-[(2Z,6Z,17Z,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8,10,13,15,17,19,21-undecaen-9-yl]propanoic acid

C41H44N4O8 (720.3159)

2-[(2R,5R,8S,11R)-5,8-bis(2-amino-2-oxoethyl)-11-[(2R,4S,5E,7E,9E)-2,4-dihydroxypentadeca-5,7,9-trienyl]-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentazacycloheptadec-2-yl]acetamide

C33H52N8O10 (720.3806)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H60O15 (720.3932)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C35H60O15 (720.3932)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C35H60O15 (720.3932)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C35H61O13P (720.385)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C35H61O13P (720.385)

[1-decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H61O13P (720.385)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C35H61O13P (720.385)

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C39H61O10P (720.4002)

1,3-thiazol-5-ylmethyl N-[(2R,3R,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate

C37H48N6O5S2 (720.3127)

[1-[(E)-dec-4-enoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H61O13P (720.385)

1,3-thiazol-5-ylmethyl N-[(2R,5S)-3-hydroxy-5-[[3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate

C37H48N6O5S2 (720.3127)

[1-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H61O13P (720.385)

Epivoacorine

C43H52N4O6 (720.3887)

DGDG O-20:3;O

C35H60O15 (720.3932)

SMGDG O-26:4;O

C35H60O13S (720.3754)

SQDG 26:3;O

C35H60O13S (720.3754)

DGGA 30:6;O

C39H60O12 (720.4085)

BMP 33:8

C39H61O10P (720.4002)

PG 18:1/11:3;O3

C35H61O13P (720.385)

PG 22:1/7:3;O3

C35H61O13P (720.385)

PG 22:2/7:2;O3

C35H61O13P (720.385)

PG 22:6/9:4;O2

C37H53O12P (720.3274)

PG 29:4;O3

C35H61O13P (720.385)

PG 31:10;O2

C37H53O12P (720.3274)

LPIM1 15:0

C30H57O17P (720.3333)

LPIP O-22:1

C31H62O14P2 (720.3615)

LPIP P-22:0

C31H62O14P2 (720.3615)

PI O-25:5;O2

C34H57O14P (720.3486)

PI O-26:4;O

C35H61O13P (720.385)

PI P-16:0/9:4;O2

C34H57O14P (720.3486)

PI P-18:0/8:3;O

C35H61O13P (720.385)

PI P-18:1/7:3;O2

C34H57O14P (720.3486)

PI P-18:1/8:2;O

C35H61O13P (720.385)

PI P-20:1/6:2;O

C35H61O13P (720.385)

PI 18:1/7:3;O

C34H57O14P (720.3486)

PI 20:3/5:1;O

C34H57O14P (720.3486)

PI 20:4/4:1;O2

C33H53O15P (720.3122)

PI 24:5;O2

C33H53O15P (720.3122)

PI 25:4;O

C34H57O14P (720.3486)

PI 22:2/4:1

C35H61O13P (720.385)

PI 26:3

C35H61O13P (720.385)

PI 4:0_22:3

C35H61O13P (720.385)

HSDVHK-NH2

C30H48N12O9 (720.3667)

HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM)[1][2].

methyl (1r,15r,17s,18s)-6-[(1r,12s,14s,15e,18s)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

(1r,4r,5r,7s,8r,9r,10r,11s,12s)-5,7-bis(acetyloxy)-10-[(3r,5s)-5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl benzoate

C40H48O12 (720.3146)

(2s,3s,4as,5r,8as)-5-[(3s)-5-(acetyloxy)-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C39H60O12 (720.4085)

(1r,3s,4s,5r,6r,8r,9r,11r,13r,14r,15s,16s)-9,11,16-tris(acetyloxy)-13-(benzoyloxy)-3,8,12,12,15-pentamethyl-7,17-dioxatetracyclo[12.2.1.0¹,⁵.0⁶,⁸]heptadecan-4-yl benzoate

C40H48O12 (720.3146)

(2s)-4-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7,11-bis(acetyloxy)-1-[(2s,3r,6s)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-2-hydroxy-2-methyl-4-oxobutanoic acid

C39H60O12 (720.4085)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-10-{[(2r,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H60O12 (720.4085)

methyl (1s)-17-ethyl-5-[(1s)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl]-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

(1s,2s,6s,7s,9r,11s,13r,14r,16r,17s)-4-methoxy-2,6,14,17-tetramethyl-3-oxo-14-[(3s)-5-oxooxolane-3-carbonyl]-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl (2e)-2-methylbut-2-enoate

C37H52O14 (720.3357)

(3e,6r)-6-hydroxy-2-methyl-5-oxo-6-[(3s,5r,6s,7s,8r,10r,12s,14r,15r,18r,19r,20r,22s,23s)-3,6,7,20-tetrahydroxy-8-(hydroxymethyl)-2,2,15,18,22-pentamethyl-16-oxo-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-19-yl]hept-3-en-2-yl acetate

C38H56O13 (720.3721)

[3,4,5-trihydroxy-6-({7-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl}oxy)oxan-2-yl]methoxysulfonic acid

C34H56O14S (720.3391)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-6-({[(2r)-2-methylbutanoyl]oxy}methyl)oxan-4-yl octanoate

C35H60O15 (720.3932)

18,24:20,24-diepoxycycloartane-3,15,16,25-tetrol; (3β,15β,16β,20s,24r)-form,3-o-beta-d-xylopyranoside,15,16-di-ac

C39H60O12 (720.4085)

{"Ingredient_id": "HBIN002079","Ingredient_name": "18,24:20,24-diepoxycycloartane-3,15,16,25-tetrol; (3\u03b2,15\u03b2,16\u03b2,20s,24r)-form,3-o-beta-d-xylopyranoside,15,16-di-ac","Alias": "NA","Ingredient_formula": "C39H60O12","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9259","PubChem_id": "NA","DrugBank_id": "NA"}

19'(s)-hydroxyconoduramine

C43H52N4O6 (720.3887)

{"Ingredient_id": "HBIN002219","Ingredient_name": "19'(s)-hydroxyconoduramine","Alias": "NA","Ingredient_formula": "C43H52N4O6","Ingredient_Smile": "CC=C1CN(C2CC3=C(C(CC1C2C(=O)OC)C4=C(C=C5C(=C4)C6=C(N5)C7(CC8CC(C7N(C8)CC6)C(C)O)C(=O)OC)OC)NC9=CC=CC=C39)C","Ingredient_weight": "720.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9932","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101254411","DrugBank_id": "NA"}

19'(s)-hydroxyconodurine

C43H52N4O6 (720.3887)

{"Ingredient_id": "HBIN002220","Ingredient_name": "19'(s)-hydroxyconodurine","Alias": "NA","Ingredient_formula": "C43H52N4O6","Ingredient_Smile": "CC=C1CN(C2CC3=C(C(CC1C2C(=O)OC)C4=C(C=CC5=C4NC6=C5CCN7CC8CC(C7C6(C8)C(=O)OC)C(C)O)OC)NC9=CC=CC=C39)C","Ingredient_weight": "720.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9933","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12112928","DrugBank_id": "NA"}

25-o-acetylbryoamaride

C38H56O13 (720.3721)

{"Ingredient_id": "HBIN004698","Ingredient_name": "25-o-acetylbryoamaride","Alias": "NA","Ingredient_formula": "C38H56O13","Ingredient_Smile": "CC(=O)OC(C)(C)CCC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3C=C(C(=O)C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)C)O)O","Ingredient_weight": "720.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "339","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101306926","DrugBank_id": "NA"}

beesioside i

C39H60O12 (720.4085)

{"Ingredient_id": "HBIN017683","Ingredient_name": "beesioside i","Alias": "NA","Ingredient_formula": "C39H60O12","Ingredient_Smile": "CC(=O)OC1C2C3(CCC(O3)(OCC24CCC56CC57CCC(C(C7CCC6C4(C1OC(=O)C)C)(C)C)OC8C(C(C(CO8)O)O)O)C(C)(C)O)C","Ingredient_weight": "720.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2200","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15908521","DrugBank_id": "NA"}

methyl (1s,15r,17s,18s)-17-ethyl-5-[(1s,12r,14s,15z,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

(3as,7as)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-1-[(2s)-2-[(1-hydroxyhexylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C35H56N6O10 (720.4058)

10-({4,5-dihydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H60O12 (720.4085)

4-[(2s,3s,4r,5r)-3-{[(2s,3s)-4-hydroxy-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butoxy]methyl}-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol

C40H48O12 (720.3146)

6-hydroxy-6-(2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O13 (720.3721)

[(2r,3s,4s,5r,6r)-6-{[(1s,2r,3as,3bs,7s,9ar,9bs,11as)-7-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

C34H56O14S (720.3391)

2-({[6-hydroxy-10-methoxy-2-(8-methoxy-8-oxooctyl)-9-methyl-3-oxo-1,4,8-trioxaspiro[4.5]decan-7-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1,9-dicarboxylic acid

C38H56O13 (720.3721)

methyl (1r,15s,17r,18r)-6-[(1s,12r,14r,15z,18r)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1r)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

4-methoxy-2,6,14,17-tetramethyl-3-oxo-14-(5-oxooxolane-3-carbonyl)-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl 2-methylbut-2-enoate

C37H52O14 (720.3357)

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-1-[(2r,4e)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-2-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-8-yl acetate

C38H56O13 (720.3721)

5,7-bis(acetyloxy)-10-[5-(acetyloxy)-3-(furan-3-yl)-2-methylcyclopent-1-en-1-yl]-9-(2-methoxy-2-oxoethyl)-4,8,10-trimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl benzoate

C40H48O12 (720.3146)

2-[(2-{[12,21-dimethyl-20-(2-methylprop-1-en-1-yl)-18,23-dioxahexacyclo[17.3.1.0³,¹⁶.0⁴,¹³.0⁷,¹².0¹⁶,²²]tricos-6-en-9-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C39H60O12 (720.4085)

3',15-dihydroxy-7,14'-dimethyl-3,9,10',11,16',18',22-heptaoxaspiro[heptacyclo[15.6.1.1⁷,¹⁰.0¹,¹⁴.0⁴,¹³.0¹⁸,²³.0¹³,²⁵]pentacosane-21,6'-hexacyclo[12.5.1.1⁵,⁸.0¹,¹¹.0²,⁸.0¹⁷,²⁰]henicosan]-18(23)-ene-2,7',9'-trione

C40H48O12 (720.3146)

(2e)-4-{[(2r,4s,5r,6s)-4-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(3s,4e,6e,9s,10r,11r,12e,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-2-yl]oxy}-4-oxobut-2-enoic acid

C39H60O12 (720.4085)

5-[5-(acetyloxy)-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C39H60O12 (720.4085)

(3e)-6-hydroxy-6-(2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O13 (720.3721)

(1s,1's,2's,3'r,4s,5's,7r,8's,10s,11's,13s,14s,14'r,15r,17s,17's,20'r,21s,25r)-3',15-dihydroxy-7,14'-dimethyl-3,9,10',11,16',18',22-heptaoxaspiro[heptacyclo[15.6.1.1⁷,¹⁰.0¹,¹⁴.0⁴,¹³.0¹⁸,²³.0¹³,²⁵]pentacosane-21,6'-hexacyclo[12.5.1.1⁵,⁸.0¹,¹¹.0²,⁸.0¹⁷,²⁰]henicosan]-18(23)-ene-2,7',9'-trione

C40H48O12 (720.3146)

methyl (1'r,2r,3s,12'r,14's,18's)-12'-[(1r,15s,17r,18r)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-7-yl]-3,17'-dimethyl-10',17'-diazaspiro[oxirane-2,15'-tetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadecane]-3'(11'),4',6',8'-tetraene-18'-carboxylate

C43H52N4O6 (720.3887)

2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl octanoate

C38H56O13 (720.3721)

1-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-8-yl acetate

C38H56O13 (720.3721)

(4ar,6ar,6bs,8as,9s,10r,12as,12bs,14br)-10-{[(2r,3s,4r,5s)-4,5-dihydroxy-3-{[(2r,3s,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H60O12 (720.4085)

6-({5-[(acetyloxy)methyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl}oxy)-2-(hydroxymethyl)-4,5-bis[(5-methylhexanoyl)oxy]oxan-3-yl 5-methylhexanoate

C35H60O15 (720.3932)

methyl 4'-[(13e)-13-ethylidene-18-(methoxycarbonyl)-4-oxo-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,5,7-trien-5-yl]-5'-methoxy-3,8'-dimethyl-8',15'-diazaspiro[oxirane-2,13'-pentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadecane]-2'(7'),3',5'-triene-18'-carboxylate

C42H48N4O7 (720.3523)

5-({5-[(1,5-dihydroxy-3-methylpent-2-en-1-ylidene)amino]-2-[(1-hydroxyethylidene)amino]pentanoyl}oxy)-n-[3-(5-{3-[(1,5-dihydroxy-3-methylpent-2-en-1-ylidene)amino]propyl}-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)propyl]-3-methylpent-2-enimidic acid

C35H56N6O10 (720.4058)

(3e,6r)-6-[(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O13 (720.3721)

methyl (13e)-13-ethylidene-4-[15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C43H52N4O6 (720.3887)

(3e,6r)-6-hydroxy-2-methyl-5-oxo-6-[(3s,5r,6s,7s,8r,10s,12s,14r,15r,18r,19r,20r,22s,23s)-3,6,7,20-tetrahydroxy-8-(hydroxymethyl)-2,2,15,18,22-pentamethyl-16-oxo-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-19-yl]hept-3-en-2-yl acetate

C38H56O13 (720.3721)

(2e)-4-{[(2r,4r,5s,6r)-2-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(3s,4z,6e,9s,10s,11r,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-4-yl]oxy}-4-oxobut-2-enoic acid

C39H60O12 (720.4085)

6-hydroxy-6-(2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-2-methyl-5-oxoheptan-2-yl acetate

C38H56O13 (720.3721)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-bis[(2-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}oxan-4-yl octanoate

C35H60O15 (720.3932)

methyl (1s,15r,17s,18s)-5-[(1s,12r,14r,15z,18s)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

methyl (13e)-13-ethylidene-4-[(15e)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C43H52N4O6 (720.3887)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3-[(2-methylbutanoyl)oxy]-5-[(3-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}oxan-4-yl octanoate

C35H60O15 (720.3932)

6-hydroxy-2-methyl-5-oxo-6-[3,6,7,20-tetrahydroxy-8-(hydroxymethyl)-2,2,15,18,22-pentamethyl-16-oxo-4,9,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-19-yl]hept-3-en-2-yl acetate

C38H56O13 (720.3721)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-5-[(3-methylbutanoyl)oxy]-3-{[(2r)-2-methylbutanoyl]oxy}-6-({[(2r)-2-methylbutanoyl]oxy}methyl)oxan-4-yl octanoate

C35H60O15 (720.3932)

n-[10-benzyl-1,8,11-trihydroxy-3-(1h-indol-3-ylmethyl)-6,13-dimethyl-4,14-dioxo-3h,6h,7h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-f]1-oxa-4,7,10,13-tetraazacyclohexadecan-7-yl]-2-phenylethanimidic acid

C40H44N6O7 (720.3271)

methyl 17-ethyl-5-[17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl]-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5s,6r)-2-{[(1s,3s,4r,9s,12r,13s,16r,19s,20s,21s,22r)-12,21-dimethyl-20-(2-methylprop-1-en-1-yl)-18,23-dioxahexacyclo[17.3.1.0³,¹⁶.0⁴,¹³.0⁷,¹².0¹⁶,²²]tricos-6-en-9-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H60O12 (720.4085)

(6r)-6-[(1r,2r,3as,3bs,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate

C38H56O13 (720.3721)

(2e)-4-[(2-hydroxy-2-{3-hydroxy-4-[(4e,6e,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-6-isopropyl-5-methyloxan-4-yl)oxy]-4-oxobut-2-enoic acid

C39H60O12 (720.4085)

(1r,2s,4r,5r,8r,9s,11r)-2-({[(2s,5r,6r,7r,9r,10r)-6-hydroxy-10-methoxy-2-(8-methoxy-8-oxooctyl)-9-methyl-3-oxo-1,4,8-trioxaspiro[4.5]decan-7-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1,9-dicarboxylic acid

C38H56O13 (720.3721)

methyl (1s,15r,17s,18s)-17-ethyl-5-[(1s,15r,17s,18s)-17-ethyl-6-methoxy-1-(methoxycarbonyl)-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl]-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

methyl (1r,9s,10s,12r,13e,18r)-13-ethylidene-4-[(1s,12r,14s,15e,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-10-hydroxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0⁹,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C43H52N4O6 (720.3887)

(2e)-5-{[(2s)-5-{[(2e)-1,5-dihydroxy-3-methylpent-2-en-1-ylidene]amino}-2-[(1-hydroxyethylidene)amino]pentanoyl]oxy}-n-{3-[(2s,5s)-5-(3-{[(2e)-1,5-dihydroxy-3-methylpent-2-en-1-ylidene]amino}propyl)-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}-3-methylpent-2-enimidic acid

C35H56N6O10 (720.4058)

(2r,3r,4s,5r,6r)-6-{[(2s,3s,4s,5r)-5-[(acetyloxy)methyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)-4,5-bis[(5-methylhexanoyl)oxy]oxan-3-yl 5-methylhexanoate

C35H60O15 (720.3932)

(3e,6r)-6-[(1r,2r,3as,3bs,8r,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O13 (720.3721)

bis((1's,3ar,4r,6's,7'r,7ar,9's)-7'-hydroxy-7a-methyl-10'-methylidene-tetrahydro-1h-3'-oxaspiro[2-benzofuran-4,5'-tricyclo[7.2.1.0¹,⁶]dodecane]-2',3,11'-trione)

C40H48O12 (720.3146)

(2r,3r,4s,5s,6r,9r,11s,14r,16s,19s,22s)-4-(acetyloxy)-22-(2-hydroxypropan-2-yl)-1,5,10,10-tetramethyl-11-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-21,25-dioxaheptacyclo[20.2.1.0²,¹⁹.0⁵,¹⁹.0⁶,¹⁶.0⁹,¹⁴.0¹⁴,¹⁶]pentacosan-3-yl acetate

C39H60O12 (720.4085)

(3e,6r)-6-[(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O13 (720.3721)

(1s,2r,3r,4s,5s,6r,9r,11s,14r,16s,19s,22s)-4-(acetyloxy)-22-(2-hydroxypropan-2-yl)-1,5,10,10-tetramethyl-11-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-21,25-dioxaheptacyclo[20.2.1.0²,¹⁹.0⁵,¹⁹.0⁶,¹⁶.0⁹,¹⁴.0¹⁴,¹⁶]pentacosan-3-yl acetate

C39H60O12 (720.4085)

(2r,3r,4s,5r,6r)-2-{[(2s,3r,4s,5s)-4-hydroxy-2,5-bis(hydroxymethyl)-3-[(3-methylbutanoyl)oxy]oxolan-2-yl]oxy}-6-(hydroxymethyl)-4,5-bis[(2-methylpropanoyl)oxy]oxan-3-yl decanoate

C35H60O15 (720.3932)

(2s,3s,4as,5r,8as)-5-[(3s)-5-(acetyloxy)-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3s,4r,5r,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C39H60O12 (720.4085)

(1r,2r,3r,4s,5r,7r,8s,9s,10r,12z,14r,17s)-2,7,9-tris(acetyloxy)-10-(butanoyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl octanoate

C38H56O13 (720.3721)

(2s,3as,7as)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-1-[(2s)-2-[(1-hydroxyhexylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C35H56N6O10 (720.4058)

methyl (1s,15r,17s,18s)-17-ethyl-5-[(1s,12r,14s,15e,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O6 (720.3887)

n-[(3s,6r,7s,10r,13r,18as)-10-benzyl-1,8,11-trihydroxy-3-(1h-indol-3-ylmethyl)-6,13-dimethyl-4,14-dioxo-3h,6h,7h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-f]1-oxa-4,7,10,13-tetraazacyclohexadecan-7-yl]-2-phenylethanimidic acid

C40H44N6O7 (720.3271)

(1s,1's,2's,3'r,4s,5's,7r,8's,10s,11's,13s,14s,14'r,15r,17s,17's,20'r,25r)-3',15-dihydroxy-7,14'-dimethyl-3,9,10',11,16',18',22-heptaoxaspiro[heptacyclo[15.6.1.1⁷,¹⁰.0¹,¹⁴.0⁴,¹³.0¹⁸,²³.0¹³,²⁵]pentacosane-21,6'-hexacyclo[12.5.1.1⁵,⁸.0¹,¹¹.0²,⁸.0¹⁷,²⁰]henicosan]-18(23)-ene-2,7',9'-trione

C40H48O12 (720.3146)